Microbot Medical (FRA:CY9D) 3-Year Book Growth Rate : -51.80% (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Microbot Medical 3-Year Book Growth Rate?

Microbot Medical's Book Value per Share for the quarter that ended in Mar. 2024 was €0.39.

During the past 12 months, Microbot Medical's average Book Value per Share Growth Rate was -28.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was -51.80% per year. During the past 5 years, the average Book Value per Share Growth Rate was -15.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Microbot Medical was 66.10% per year. The lowest was -87.00% per year. And the median was -18.10% per year.

Competitive Comparison of Microbot Medical's 3-Year Book Growth Rate

For the Medical Instruments & Supplies subindustry, Microbot Medical's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microbot Medical's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Microbot Medical's 3-Year Book Growth Rate falls into.

Microbot Medical 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Microbot Medical (FRA:CY9D) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Microbot Medical 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Microbot Medical's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbot Medical (FRA:CY9D) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (FRA:CY9D) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

MBOT:USA CY9D:Germany

Address

25 Recreation Park Drive, Unit 108, Hingham, MA, USA, 02043

Website

https://microbotmedical.com

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Microbot Medical (FRA:CY9D) Headlines

No Headlines